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Abstract 
Reproductive behavioural patterns are undoubtedly changing with the increasing 
popularity of Assisted Reproductive Technologies (ART). While fulfilling a couple’s wish to 
be parents, the social value of ART is not easy to quantify. This work project aims at quantifying 
this by measuring the economic value that one person adds to the state, by creating a model that 
calculates net transfers with the state throughout the individual’s lifetime. Under average 
circumstances, the Net Present Value (NPV) of an ART-conceived individual was calculated 
to be € 20,424.96. Different scenarios were tested, and the work component (namely taxes and 
pensions) was found to be the most determinant element. 
 
Key Words: Assisted Reproductive Technology, Economic Value of ART, Long-term 
impact of ART  
2 
 
1. Introduction 
Human infertility is a complex condition, which may be caused by several mechanisms – 
some are curable, but others are not. For cases with no natural solution, ART has appeared as a 
substitutive method. As it becomes more common, it is important to carefully study ART’s 
implications, in several spheres. Hence, the investigation question behind this paper was “What 
is the social value of ART?” and it was answered from an economic perspective, by measuring 
the value that ART creates in the relationship between an individual and the state of Portugal. 
In order to quantify it in a considered manner, a model was developed to assess financial 
transfers between an average individual and the state and, by comparison, to evaluate if a 
medically assisted conception would decrease this value. The conclusion was that under 
average circumstances, the NPV of an ART-conceived individual is € 20,424.96. Several 
scenarios were considered in order to understand what could significantly change this value and 
the lowest calculated NPV was equal to -€ 6925.04, in a scenario considering a discount rate of 
7%. The paper further compares results to similar models from the existing literature, allowing 
for an assessment of where Portugal lies in contrast with other countries – overall corresponding 
to the 8th highest NPV (out of 14), under average conditions. 
 The general structure of the paper is as follows: section 1 consists of an introduction, 
section 2 provides general information on infertility and ART, section 3 presents further 
literature review, section 4 describes the methodology used to develop the model, section 5 
introduces the results from the model, and section 6 presents final remarks. 
2. Background: Infertility and ART 
The incapacity to bear children is tragic for numerous people around the world, being 
impactful on physical, psychological and social levels. The condition is described by the World 
Health Organization as “a disease of the reproductive system, defined by the failure to achieve 
a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.” (WHO, 
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2018). The concept of infertility is debated, as are many aspects around the topic – definitions 
and concepts vary across countries, languages and contexts. This contributes to challenges in 
sharing and reporting information (Zegers-Hochschild, 2009).  
Despite the struggle in identifying authentic cases of infertility, the most recent studies 
estimate it affects between 8 and 12% of couples in the reproductive age stage worldwide 
(Wyns, 2018). In 10 to 20% of cases, no cause is identified (ESHRE, 2018). Several lifestyle 
aspects have been related to infertility (such as bodyweight, stress and tobacco). Age is also a 
key factor: fertility starts declining when women are around 25-30 years old, and most studies 
suggest women are only able to conceive unaided until they are 40-41 (Wyns, 2018). This is 
especially relevant nowadays as offspring are more frequently delayed for various reasons – a 
key trend being that while women previously often dedicated their lives to motherhood, many 
now work. Personal and socio-economic factors create tension between couples’ desire to have 
children and, at the same time, the need to delay their births (Habbema, 2015). This increases 
the number of women who cannot successfully carry children, and thus widens the fertility gap 
(the difference between the desired or planned number of children and the actual one). 
Infertility not only affects couples at a personal level, but also impacts society on a larger 
scale. We presently live in a world that simultaneously desperately needs to control its 
population growth while paradoxically facing a fertility issue. On one side, it is obvious that 
many regions are overpopulated, resulting in inefficient sharing of resources and enhanced 
inequality; on the other, it becomes evident that the increasing prevalence of infertility is 
happening simultaneous to a preference for a small family, which has been progressively 
adopted in the Western world. According to the World Bank, Portugal’s fertility rate in 2016 
was of 1.31 births per woman (The World Bank, 2017) – far from 2.1, the generally accepted 
level to stabilize the population structure (Hoorens, 2007). 
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The reduced number of births, the ageing population, the smaller family pattern and the 
outward migration trends combine to invert the population pyramid; while the structure of the 
population decisively affects the balance of public budgets. By dividing a population into 3 
major age groups, one can visualize a lifecycle of interactions with the state, in which an 
individual is a net receiver, then a contributor, and then a receiver again. Net receivers use 
services without contributing to the budget at that time. Net contributors, on the other hand, 
must provide enough to off-set government spending with benefits and services for themselves 
and for net receivers (Pinheiro, 2018). The inverted population pyramid contributes to an 
unbalance between these two roles. In 2016, Portugal presented an old-age dependency ratio of 
31.8 per 100 working people (Eurostat, 2018). A higher dependency causes economic issues 
such as heavier tax burdens on certain generations; a smaller population base from which to 
collect taxes, possibly leading to the insolvency of certain institutions or funds; amongst others. 
Such an imbalance is likely to be heightened as fertility rates remain below replenishment 
levels. ART may therefore mitigate some of the consequences of infertility: on one side by 
contributing, even if marginally, for the country to have a stable population, adequately 
distributed amongst the age groups, which generates healthier public finances; and on the other 
side by allowing couples to accomplish their profound aspirations to become parents. 
ART is the name for all procedures performed to generate a pregnancy which involve in 
vitro manipulation of gametes or embryos. It includes In-Vitro Fertilization (IVF), Intra-
Cytoplasmatic Sperm Injection (ICSI) with embryo transfer, and others (Zegers-Hochschild, 
2009). Its history began 40 years ago, with the first IVF-conceived baby; and, though it is hard 
to precisely establish numbers, it is estimated that about 0.1% of the total world population has 
now been conceived through ART (Faddy, 2018). This translates to over 7 million babies – 
most of whom born to women aged between 30 and 39 (ESHRE, 2018). In the most recent 
statistics by ESHRE from 2014, 39 European countries reported a total of close to 800.000 IVF 
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births (ESHRE, 2018). Countries like Korea and Sweden have optimized public subsidy of ART 
in order to compensate for their low birth rates (Connolly, 2009). In Portugal, ART started in 
July 1985 and, currently, 27 centres are authorized to perform ART procedures (10 public and 
17 private), resulting in 2,504 births in 2015 – amounting to 2.9% of all births in the same year. 
The overall demand for these procedures is increasing, but national and international figures 
are still far from the projected total global needs, although the availability of ART has increased 
greatly, due to both a better coverage and socio-cultural aspects (Ferraretti, 2017). 
There are several factors influencing the total usage of ART. Two are obviously medical 
recommendation and legality, which depend on each country’s specific legislation. In Portugal, 
the initial law established that ART could only be accessed by infertile couples, but it has since 
been changed to include a broader group of people (Diário da República, 2017). Another factor 
is the accessibility to ART – while financial resources were initially thought to be the most 
determinant factor, several studies have proved accessibility to be more relevant. State 
subsidies, ease in obtaining loans, insurance protocols, and other practices enable average 
couples to undertake such investments (Chambers, 2014). Countries with reimbursement plans 
achieve higher utilization rates, as couples bear the investment upfront but get paid back (Ata, 
2010). Other social factors, such as culture, have been found to be relevant – even when 
affordability is not an issue, a couple will not undergo ART if it is not an acceptable practice in 
society (Präg, 2017). These are all important aspects to consider when designing subsidy 
policies. ART is often seen by many of the involved parties as a medical luxury, making it 
susceptible to financing cuts, despite the empirical evidence that it represents a safe financial 
investment (Molenaar, 2014). Further studying and evaluating the economic value of ART may 
be important for policy design. 
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3. Literature Review 
For the literature review, several databases (especially, but not only, PubMed) were used. 
Research keywords included “Economic value of ART”, “Long-term financial impact of ART”, 
amongst others; the research was as exhaustive as possible but with limitations, as this study is 
not meant as a meta-analysis. After careful publication review, 9 articles were found to use a 
similar approach, suggesting it is possible to perform such a study and that its methodology is 
already relatively standardized. Overall, most authors considered that ART presents an 
attractive return on investment in their respective countries, even though values may vary. 
Values are adjusted to each country’s specificities – different social security policies, tax rates, 
and legislative frameworks governing financial interactions. Specific results of these articles 
are further-on discussed, in comparison to the ones from this study. 
In spite of ART being a fairly recent technique, its economic value has already been 
subject to several studies. Authors have tried to assess it through quantification of the monetary 
benefits accruing to the state attributed to ART-conceived individuals. These studies made it 
possible to evaluate if the economic value attributed to ART is enough to offset the initial 
investment it carries or if ART is being funded by taxes and represents a financial burden on 
the rest of society. The methodology they use is based on Generational Accounting (GA). 
GA is used to calculate the fiscal burden that living generations face, according to current 
fiscal conditions and extrapolating them onto future generations (Kotlikoff, 1994). The main 
goal of GA is to understand if the current fiscal policies are designed to sustain governmental 
programs – that is, if the tax burden is evenly distributed across generations, or if a past 
generation has left the future ones in debt, or if the current one will do so (Auerbach, 1999). 
Applied to ART, this methodology enables value measurement by quantifying the economic 
transfers generated by an individual during their lifetime. These include any benefits that an 
average individual will receive in a lifetime, such as health and education, as well as one’s dues 
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such as income tax, value added taxes, old-age pensions, amongst others.  Net contributions are 
calculated by adding both “both positive and negative transfers to and from the state (Molenaar, 
2014), and a final NPV is calculated by discounting these transfers to the present year. This 
general framework ultimately allows to assess whether an ART-conceived individual is a net 
receiver or contributor to public finances. 
 
4. Methodology 
A) Qualitative description of model and its assumptions 
After the literature review, a baseline approach was designed: a GA based model was 
built to estimate financial transactions between ART-conceived singletons and the Portuguese 
government over their projected lifetime. Given the predictable expenditures and revenues at 
each age, the net financial contribution (NFC) of each individual per category i, at year t, was 
calculated as the sum of all economic components. The equation underlying this calculation is 
the following: (1) NFCt = Tt - H t - E t - PS t, where NFCt represents net transfers of an individual 
at any given point in time t, T is the tax revenue that the government receives, H represents 
healthcare costs, E represents education benefits and PS represents pensions. Applying this 
equation results in a net tax contribution or deficit to the state, at each moment in time, t. 
Subsequently, the NPV was derived as the sum of the NFC for each year, multiplied by 
the discount factor and the probability of being alive. This is demonstrated by the baseline 
equation: (2) NPV = ∑  𝑡 ∑  𝑖 𝑔𝑖𝑡𝛽
𝑡𝜋𝑡 − 𝐼0
𝑡 = ∑ 𝑁𝑡𝛽
𝑡 
𝑡 𝜋𝑡, where t represents each time period, i 
is a given item from public finances, git is the public expense (if <0) or gain (if >0) per individual 
in category i at time t (NFC in formula(1)), β is the discount factor (𝛽 =
1
1+𝑟
, where r is the rate 
of discount), πt is the probability of being alive at time t and I0 is the initial investment in ART. 
An initial base-case scenario was defined, and different scenarios were tested afterwards. 
Several assumptions were made, in order to simplify and give consistency and structure to the 
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model (described on table 1). The first one was that the new-born individual was considered 
average in all aspects – education, earnings and health. This assumption is based i) on the fact 
that no homogeneity was found in the profiles of individuals using ART – that is, couples which 
undertake ART may be represented by a random sample of the population; and ii) no specific 
life trajectory for ART-conceived individuals was so far described and correlated with the 
techniques. Namely, ART does not determine that individuals are more prone to any health 
condition, social status, or academic or work path. An IVF-conceived 23-year-old girl was 
inclusively interviewed for empirical information on her life-course (MCR, 2018).  
 
Table 1 - Main assumptions undertaken for base-case scenario 
Furthermore, the individual was expected to live through the average life expectancy 
(81.3 years old, as defined by PorData). Age Specific Death Rates (ASDR) were used for the 
probability of the individual to be alive at each point in time – these were derived from a GA 
model developed for Portugal (Pinheiro, 2018). A typical life trajectory was established and 
divided into six major phases: i) Pre-school: 0-6 years old; ii) Primary Education: 6-15 years 
Main  assumptions for base-case scenario
Reference Year
Assumed to be 2016 as it was the most recent year with the most available information. All other values 
were adjusted for inflation rates.
Gender No specific gender was assumed, values used were average for the two genders.
Family
Individual was assumed to be single and without dependents for the entire lifetime. Considering the 
impact of offspring could be crucial.
Health
Healthy individual; no specific diagnosis; no chronic medication; average health events (i.e. some trips to 
emergency room and regular appointments and exams). No difference between ART-conceived 
individual and any other one.
Birth Normal delivery, no complications associated to labour or delivery.
Life-expectancy and death Average life-expectancy (82 years old); dies of old age, receiving long-term care.
Age-specific death rates Specific death-rates/ probabilities of being alive were used for each age; derived from GA article.
National Health System
The individual is considered to be a SNS user, disposing of its resources when needed, and not being 
financed by any specific private insurance.
Education
Average education for the predicted duration, no failing; pre-school followed by 12 years of basic school 
and university (both Bachelors and Masters studies).
Type Public school for the entire trajectory.
Work
Public worker, always employed. Wages paid by state (here considered as a different entity - i.e. wages 
are not considered negative transfers for the state).
Starting age Starting at 22 years old, imediately after conclusion of master studies.
Wages Initial wage correspondent to the 75% of average wage in 2016 and growing at 2% per year.
Retirement At approximately the reference age for 2016, 66 years old.
Pensions
Receiving exclusively the old-age pension, starting at 67 only and lasting until death; calculated according 
to specification by the Social Security.
Tax Included taxes for consumption, wages and contributory tax to Social Security.
IVA All disposable income was taxed.
Discount rate Assumed to be 3.5% as in other studies.
Macroeconomic values Assumed to remain constant.
ART price Calculated as a weighted average between the 3 most common techniques in Portugal (ICSI, IUI and IVF).
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old; iii) Secondary Education: 15-18 years old; iv) Superior Education: 18-21 years old; v) 
Employment: 22-65 years old; vi) Retirement: over 66 years old.  
The base-case year was set as 2016, as it was the latest year for which most necessary 
data was available. Values from earlier years were adjusted for inflation. Regarding the discount 
rate, there is frequently some uncertainty around the proper value to use. It is mainly influenced 
by the risk regarding public revenues and expenditures (Pinheiro, 2018), which differs between 
countries. As the value depends significantly on the outlook of sustainability of public finances, 
for Portugal, forecasting an accurate value is challenging, as the 2011 crisis was extremely 
impactful – even requiring financial aid from the EU – and thus the global economic context is 
hard to predict. Taking this in consideration, a discount rate of 3.5% was used for the base-case, 
similarly to studies for the UK and Spain. Inflation was not explicitly considered but is 
implicitly accounted for in the growth of nominal values, as these change according to general 
inflation, mimicking current patterns; the error associated with trying to predict future inflation 
rates would be too large. Other unmentioned economic values were also assumed to evolve 
with the global economy.  
The price of ART was considered an initial investment and subtracted from the measured 
NPV for a statistical life. This price was a weighted average between the 3 most common 
techniques in Portugal (ICSI, IUI and IVF). These respective prices were also calculated as an 
average of the prices of the currently authorized centres in the country, as detailed in their 
websites (values for 2018, detailed on table 1 of Appendix 2). Assumptions specific to each 
public finance item are detailed on the next section. 
B) Quantification of net transfers 
The central challenge of this investigation was indeed to quantify each element and define 
net transfer values for the considered categories (health, education and labour pensions). 
Several sources were used, such as 1) Instituto Nacional de Estatística’s (INE) large public 
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database from which many values were inferred, particularly from the IDEF 2015/2016 report; 
2) PorData, a database using information from official sources, which is organized into a 
contemporary compilation of important statistics for Portugal and Europe; 3) Diagnosis Related 
Group reference values (DRG), established by the Ministry of Health to serve as references for 
hospitals and healthcare centres to define their prices; 4) Other sources included the OECD, the 
World Bank, the WHO, the Ministry of Education and Court of Auditors, amongst others. The 
results were integrated into an Excel spreadsheet (refer to table 1 in Appendix 1 to visualize its 
structure), which generally followed the above-mentioned equation for the NPV, adding the 
NFCs for each category, discounted to the present year and added across the years. 
1) Health: Studies looking for possible differences between health conditions in ART and 
normally conceived individuals were considered, but none highlighted significant disparities. 
The need for more studies is pressing, not only to understand ART’s potential impact in health 
matters, but also to prevent avoidable complications, if they do exist (Fauser, 2014) (Mulder, 
2018). Some differences were found but were mostly attributed either to the underlying causes 
of infertility or to the advanced age of the mother (TACOG, 2016). Therefore, the individual 
was considered to undergo average health events, and also to be a National Health System 
(SNS) user as opposed to having a private insurance. The assumptions underlying net transfer 
calculations are described below. These transfers result in expenses for the state. 
i) Delivery costs were for normal vaginal births, as there are no studies confirming the 
need for any specific measures for the delivery of an ART-conceived individual. The DRG 
value was used (DRG 560, Severity Level 2): € 667.911. These DRGs were established in 2015 
and were not adjusted for 2016, as they are reference values and would still be in use by 
hospitals then. 
                                                          
1 Alternatively, to account for the presumably higher probability of prematurity, the value for preterm labour could have 
been used (DRG 563, Severity Level 2), € 980.72 (Diário da República, 2015). 
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ii) Hospital stays were firstly distributed amongst the age groups. Data for this 
distribution was not easy to find, as there is no official estimation. However, a study from the 
Directorate General of Health (DGS) that collected important figures for morbidity and 
mortality in hospitals in 2013 allowed for these calculations (Nogueira, 2015). After obtaining 
the proportions for each age group, the total number of hospital stays (in days) was calculated 
using the figures available from PorData. For continental Portugal, the number was clear 
(6.938.958 days) but for the autonomous regions, an average number of days per stay was 
calculated (and found to be equal to 6) and multiplied by the number of total stays, available in 
the same database. This distribution assigned 53% of total costs to individuals over 65 years 
old, consistent with other studies completed in Portugal (DGS, 2014). All these stays were 
assumed to take place at public hospitals. A total of 7.265.732 was obtained and multiplied by 
the average price, € 889.7, an average value calculated for 2014 by the Portuguese Healthcare 
Regulation Authority (Soares, 2014) and adjusted for inflation until 2016. This average value 
takes into consideration the most expensive cases but also the cheapest ones – further studies 
could increase accuracy by calculating a weighted average considering the relative frequency 
of each type of stay. The costs for each age group were then divided by the total population in 
each of them, as provided by INE. It required some adjustments, as the division in age-groups 
was not an exact match – hence, for each age-group in the INE tables, an equal distribution per 
year was assumed. After costs were assigned to each group, they were divided by the number 
of years in the age group correspondent to INE’s (once again assuming an equal distribution), 
in order to calculate how much one individual spends in hospital stays per year. This assumption 
is fairly inconsequent, as the total figure will still be attributed to the same person, and the years 
at which the cost will take place are not so distant for the difference to be relevant. 
iii) Appointments with doctors were also distributed amongst age groups and 
specialties. Only appointments in the SNS were measured, and two types were considered – 
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hospital and health centers. For the former, the total number was provided by PorData and the 
age proportion was replicated from a study conducted for the CHLN (Sousa, 2014). For the 
latter, the number of appointments per age group was provided by a study on Primary 
Healthcare by the Independent Syndicate of Doctors (SIM, 2017). Values used were calculated 
for people with no diagnosed diseases (as we are assuming the average individual to be healthy). 
For both types of consultations, the average price was assumed to be given by the DRG value 
(with a weighted average between the price of first appointments and follow-ups).  
iv) Emergency room: The total number of 6.405.707 was retrieved from a report by the 
Ministry of Health (Minitério da Saúde, 2016). The average price was the DRG value for 
Serviço de Urgência Médico-Cirúrgico, the second type of emergency episode considered in 
the SNS (Diário da Repúbloca, 2017). The age distribution was retrieved from the 1st report.  
v) Long-term care (LTC): the information available for Portugal is limited and does not 
allow for calculations to determine the specific probability of one eventually needing LTC, nor 
the average duration per person. Therefore, estimations for the USA were used as a proxy 
(Kemper, 2005) and the average price was retrieved from an article for Portugal (Pereira, 2011) 
and adjusted for 2016, according to inflation rates and in the absence of a specific price index. 
Individuals were considered to need LTC for the last three years of their lifetime. 
2) Education: There is no evidence of causal relationships between being ART-conceived 
and receiving better education. Hence, calculations were made for an average student in a public 
school – the Portuguese Education system offers Pre-school from 3 to 6 years old, followed by 
Basic-School – 1st cycle for 4 years, 2nd cycle for 2, 3rd for 3 others – and 
Secondary/Professional School for 3 years. After this, education is optional but there are several 
public universities at accessible prices, with Bachelor-studies lasting for an average 3 years and 
Master-studies for another 1 or 2 (a 1,5 year-long masters was considered). Resulting transfers 
are expenses for the state. 
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i) Pre-school: OECD reported the annual average cost per child in Portugal to be € 5,932 
(Silva, 2017). Adjusting for 2016, a value of € 5,896.6. 
ii) Basic School: in 2012, the Portuguese government requested a study to determine the 
amount that the Ministry of Education and Culture paid for the entire compulsory education of 
one student. Adjusting for inflation, € 372.10 were assumed for each of the 12 years of studies.  
iii) University (Superior) Education: the government budget for 2016 planned a € 1.055 
billion for superior education. Divided by the total number of students (figure provided by 
PorData), each student will cost the government approximately € 2,960 for education purposes. 
3) Work and tax: As for the other categories, there are no indications that ART-conceived 
individuals will have a different work trajectory than normally conceived ones. The individual 
was hence considered to start working at the age of 22, after achieving a master’s degree. 
Considering a 4.5-year long University studies, the individual would only be working for the 
second-half of the 22nd year. Retirement age was established right after 66 years old, as the 
reference for 2016 was 66.3 years old (Diário da República, 2014). The individual was 
considered a public worker, but wages were not accounted for as transfers with the state. 
i) Wages: the starting wage was assumed to be € 693.68, 75% of the average wage in 
2016, as provided by PorData. Only a percentage of the average value was considered, i) in 
order to acknowledge that initial salary values are generally lower that the average wage, and 
ii) at the same time maintaining the assumption that the individual is average (and hence starting 
with the minimum wage would not be logical). An annual growth rate of 2% was applied to 
simulate a typical career progression. This value was calculated based on a study from the Bank 
of Portugal (Banco de Portugal, BP) (Portugal, 2018), which presents real values for average 
salary per age, not conditional to other factors. This allows for the calculation of a growth rate 
for each year, the average of which was found to be the 2% rate used. However, two important 
findings arose from this study. Firstly, salary decreases after the age of 44, which presently may 
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mean that this age group of the labour force is less educated. This emphasizes the relevance of 
considering conditional values. Secondly, salary increases more rapidly in the initial years of 
work. This may mean that applying an average growth rate will underestimate the global effect. 
These findings were not incorporated in the base-case scenario, but in an alternative scenario. 
ii) Imposto sobre o Rendimento de Pessoas Singulares: the IRS is the tax that any 
individual must pay on his earnings over a certain amount. The taxed rate depends on the total 
annual wages, varying with career progression. Reference tables for a single individual with no 
dependent household members for 2016 were used (ATA, 2018). In further studies, it would be 
interesting to consider an eventual marriage and children; this analysis was not performed. The 
net transfer of IRS represents a gain for the state. 
iii) Imposto sobre o Valor Acrescentado: IVA is the tax applied to consumption. It was 
calculated by estimating an average tax rate per age group and then applying it to the disposable 
income (DI)2. To do this, initially, consumption was derived from the IDEF and summed for 
each age group. It was then divided amongst the number of individuals inquired, to obtain an 
average consumption per type of service or good per individual. Afterwards, official tax rates 
per category were applied to each type of service or good in each age group, and total IVA per 
age group was compared to total consumption, in order to calculate an average tax rate per age-
group, derived from real-life findings and then applied to DI. 
iv) Contributory tax: according to the legislation, Social Security (SS) must receive a 
total of 34.75% of earned wages, as a contributory tax, paid by both the individual (11% of the 
wage) and the company employing the individual (23.5% over the earned wage). These rates 
were applied to annual salaries and resulted in net positive transfers to the state. 
                                                          
2 DI was calculated by multiplying total available earnings (wages minus taxes: IRS and contributory tax) by the consumption 
rate (1-average saving rate per age-group, as detailed in the IDEF). DI was assumed as what each individual can freely and will 
fully spend on various goods). 
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v) Old-age pension: access to old-age pensions is regulated according to the contributory 
career made by the individual – that is, the pension value is dependent on the total tax paid 
during lifetime. The longer the individual works, and the higher the wages received, the higher 
the tax paid, and hence the larger the pensions. Pension rates are updated annually and take into 
consideration several indicators such as the GDP and the variation in average consumer prices 
(SS, 2018). A monthly value of € 1060.84 was obtained using SS specific indications, and it 
represents an expense for the state. 
C) Sensitivity & Scenario analysis 
As mentioned above, the initial case was built assuming an average individual, but for a 
broader perspective, a sensitivity analysis was performed. Different scenarios were tested 
presuming the exact same conditions as the base-case, except for changes in one single variable. 
Table 2 in Appendix 1 shows scenario characteristics and results. Scenarios were as follows 
(numbers correspond to scenario numbers): 1, 2: changed variable was the discount rate, 
considering values of 1% and 7%; 3, 4: the highest and lowest values found for ART price in 
the existing literature were used (Brazil and UK, respectively); 5, 6: retirement was considered 
at the age of 60 and 70 years old; 7, 8: scenarios assumed an initial wage correspondent to the 
minimum and to 1.5x the average wage; 9, 10: annual wage growth rates of 0% and of 4.5% 
before 44 years old and 0% after were assumed; 11, 12: instead of assuming permanent 
employment, employment rates per age (as of 2016) were considered, or one year of 
unemployment every 5 years – an unemployment pension was considered for the unemployed 
years, calculated with specific SS indications and otherwise, similar conditions were considered 
(e.g. expenditure and consequent taxes remain equal to the previous year and wages increase at 
the same rate as before); 13, 14: the individual was assumed to attend public school but only 
for basic education or only private school, including university; 15, 16: the considered life 
expectancy was of only 66 years or up to 90 years old. 
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5. Results 
For the base-case scenario, a total NPV of € 20,424.96 was calculated for the average ART-
conceived individual, compared to the € 23,734.54 correspondent to the average naturally conceived 
one. For the ART-conceived, the break-even age was reached at 38, two years after the naturally 
conceived individual. The average individual was estimated to generate a total of € 80,437.83 in 
revenues, through the respective lifetime. Furthermore, considering ART as an initial investment, its 
rate of return was calculated as 6.17. Though values are aligned with literature review in suggesting that 
ART may be a safe investment, it is important to remember that the developed model underestimates 
the total incremental economic value of a new individual for the state, as it considers only his/her fiscal 
consequences but not those of the individual’s offspring – suggesting total value could be higher. 
 
Graph 1 – Cumulative NPV curve for the average lifetime 
Graph 1 shows the slope that results from plotting the NPV results against time. It is a 
downward sloping line in the beginning, as education is the main cost for the government and 
the individual is considered a net receiver. The line starts rising when the individual begins 
working and becomes a net contributor. It eventually crosses the axis when the NPV equals 
zero, at the break-even age. Before retirement, the maximum NPV is reached and with 
retirement, the slope once again turns down, as tax contributions decrease while benefits are 
still transferred from the state to the individual, for a decreasing NPV.  
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The results for the base-case scenario were in line with literature review findings. Table 
2 presents the outcomes for other countries in which similar studies have been conducted, 
including the ones of this study, for comparison. Denmark presents the highest NPV, about 7.5 
times the NPV calculated for Portugal, while Spain’s is only 2.2 times this value. Only the 
Netherlands and Brazil (and Portugal, under certain economic circumstances) obtained a 
negative NPV. Overall, Portugal’s values corresponded to the 8th and 13th highest values (with 
discount rates of 3.5% and 7%, respectively), which may be a consequence of varied economic 
and socio-political aspects. In fact, certain values involved in the calculations have simple 
interpretations. For example, the price of ART will reflect the costliness of the underlying 
healthcare system, as well as the impact of subsidy policies and insurance mandates (Chambers, 
2009). Tax contributions can be higher if higher tax rates are established, often seen in 
unfavourable economic contexts or when a country is trying to recover from a post-crisis. 
Revenues per individual also translate the cost of living in each country – e.g. the UK will have 
individuals generating higher nominal revenues, but a lower return rate, as the initial investment 
is higher. The rate of return (calculated as the NPV of the ART-conceived individual over the 
initial investment) simultaneously considers the cost of living and of the underlying health 
system.  
 
Table 2 – Comparison between the investigation’s results and findings from literature review. 
Country
Discoun
t rate
NPV
Break-
even 
age
Nr NPV NPV (€)*
Break-
even age
Tax 
contribution
Revenues 
per 
individual
Cost of IVF
Cost of IVF 
(€) *
NRI
Belarus (1) 9  $           21,702.00  €    19,097.76 5,509.00$       €     4,847.92 
Brazil (2) 4%  $     83,486.65 31 4  $           61,428.65  €    54,057.21 40  $   22,058.00  €   19,411.04 
7%  $     21,494.86 32 12  $                -563.00 -€          495.44 -  $   22,057.86  €   19,410.92 
Denmark (3) 1  €        154,100.00  €  154,100.00 
Greece (4) 39 3  €           60,435.00  €    60,435.00 39-41  €   133,947.00  €   17,015.00  €   17,015.00 1.82
Kazhakhstan (1) 11  $             2,295.00  €       2,019.60 
Japan (5)  $     3,956.00 
Portugal 3.5%  €     23,734.54 36 8  €           20,424.96  €    20,424.96 38  €    80,437.83  €     3,309.58 6.17
7% -€       3,615.47 0 13 -€             6,925.04 -€      6,925.04 0  €    21,032.38 -2.09
Spain (6) 3.5%  €     54,672.00 5  €           45,672.00  €    45,672.00 34  €  534,624.00  €     9,000.00  €     9,000.00 5.07
5%  €     40,868.00 6  €           31,868.00  €    31,868.00 38  €  280,062.00 3.54
Sweden (7) 40 7  SEK   254,000.00  €    24,638.00 41
The Netherlands (8) 70,392.00-€     14 -€          81,374.00 -€    81,374.00 
Ukraine (1) 10  $             9,839.00  €       8,658.32  $     2,599.00  €     2,287.12 
United Kingdom (9) 3.5%  £   122,127.00 2  £        109,939.00  €  122,032.29  £   603,000.00  £   12,931.00  €   14,353.41 8.50
References and notes: (1) Mandrik O, K. S. (2015). Economic value of in vitro fertilization in Ukraine, Belarus and Kazakhstan. ClinicoEconomics and Outcomes Research, 347-356. (2) 
Kröger GB, E. D. (2011). The fiscal outcome of artificil conception in Brazil - creating citizens in developing countries. Human Reproduction, 142-145. (3) Connolly MP, P. M. (2011). The long-
term fiscal impact of funding cuts to Danish public fertility clinics. Reproductive Biomedicine Online. (4) Fragoulakis V, M. N. (2017). Estimating the long-term effects of in vitro fertilization in 
Greece: an analysis based on a lifetime-investment model. ClinicoEconomis and Outcomes Research, 247-255. (5) Chambers GM, S. A. (2009). The economic impact of assisted reproductive 
technology: a review of selected developed countries. Fertility and Sterility, 2281-2894. (6) Villoro R, G.-D. A.-C. (2013). Long-term fiscal implications of funding assisted reproductive 
therapies: A generational accouting model for Spain. ISPOR 16th annual european congress. Dublin. (7) Svensson A, C. M. (2008). Long-term fiscal implications of subsidizing in-vitro 
fertilization in Sweden: a lifetime tax perspective. Scandinavian Journal of Public Health, 841-849. (8) Molenaar LM, C. M. (2014). Costs and benefits of individuals conceived after IVVF: a net 
tax evaluation in The Netherlands. Reproductive BioMedicine Online, 239-245. (9) Connolly M, G. F. (2009). Assessing long-run economic beneﬁts attributed to an IVF-conceived singleton 
based on projected lifetime net tax contributions in the UK. Human Reproduction, Vol 24, No 3. 626-632. (Nr) is the number correspondent to the ordering of NPV values from largest (1) to 
smaller (14) (*) Conversion rates were used as of December 2018. (NPV) Net Present Value. (NRI) Net return on investment.
Naturally conceived Art conceived individuals
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As for the sensitivity and scenario analysis, several possibilities were considered, as 
described above. Results are presented in table 2 in Appendix 1, and the respective NPVs were 
plotted in Graph 1 on Appendix 2, for easier visualization. These scenarios were useful to 
understand which finance item’s value changes are more impactful and how they affect the 
NPV. Overall, the NPV was predominantly positive, despite variation. However, ART resulted 
in an expense for the state under 4 scenarios i) when the discount rate was 7%, ii) when there 
was no wage growth, iii) when the individual was unemployed for 1 year, every 5 years, and 
iv) when the individual lived to 90 years old. This is an important investigation, to determine 
the circumstances under which ART may be prejudicial for the state (ignoring other possible 
non-economic social benefits). Underlying these results is the important finding that career 
progression and consequent taxes and pensions are the most impactful factors. This is also 
supported by the characteristics of the scenario resulting in the highest NPV - its initial wage 
was 1.5x the average salary. The impact of the work component on the final NPV is only logical, 
as most contributions from the individual to the state arise from taxes on earnings and 
consumption, and these same earnings determine to what the benefits received will amount.  
 Other important conclusions were inferred. i) If the economic context is unfavourable 
and consequently the discount rate is higher, the NPV will lower. ii) A higher ART price will 
decrease the NPV but will not make it negative, taking into consideration average prices in 
Portugal. iii) An earlier retirement will decrease the NPV, but so will a later one, as a longer 
contributory career generally means higher wages and hence higher pensions with state 
expenses increasing. iv) Lower or higher initial wages are both impactful. v) If there is no 
annual wage growth, the NPV will strongly decrease. Furthermore, an annual growth that takes 
into consideration a more realistic career progression, by growing at a rate of 4.5% before the 
age of 44 and then stabilizing, will provide a very interesting scenario. It captures the impact of 
an initial rapid growth (with a consequent earlier break-even age, and heavy contributions 
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which will be less discounted by the cost of capital – resulting in a higher NPV) serving as a 
realistic proxy. vi) Unemployment, too, will have an impact, decreasing the total NPV by 
reducing tax contributions and increasing negative transfers for the state, through pensions. vii) 
A different academic may increase the NPV. If costs with education are lower, or even non-
existent to the state, the NPV will be higher and the break-even will be reached earlier, as 
education costs are significant negative transfers, in earlier stages of life. viii) Lastly, a shorter 
or longer life will be impactful, with the individual having more value to the government if 
dying earlier, before retirement, and a lower value if dying long after retirement.  
6. Final Remarks  
The results of this investigation confirm that, if ART is considered an investment by the 
government and its return is measured by an economic model that assesses the financial 
transfers between the generated individual and the state, investing in these techniques is not 
harmful for public finance, under the most reasonable scenarios. The fact that the resulting NPV 
is most frequently positive can be interpreted as an indication that ART is an attractive 
investment to the state, and hence funding it represents a good use of public resources, as it will 
likely generate economic rewards in the future. This may even be the case for countries with 
less prosperous economies, especially if considering other benefits. These could be the 
economic benefits related to an individual’s offspring, which would also be impactful in the 
long-term, or other non-economic benefits. Some may be the overall effect of closing the 
fertility gap, with subsequent demographic and fiscal effects, but also the mitigation of 
infertility’s psychological, social and even clinical consequences.  
Another important finding from this study was the different impact of the categories of 
financial transfers with the state (health, education and work). Transfers such as tax and 
pensions, which are related to labour (and especially to wages) were the most determinant for 
the final results. This is so because firstly, positive contributions to the state are all determined 
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by the individual’s earnings (IRS and contributory tax depend on wages, IVA depends on 
consumption which depends on disposable income, which depends on earnings); secondly, 
pensions depend on how much the individual has contributed to the government through tax, 
and the smaller the pension, the more is retained by the government.  
Regarding health, its costs for the government are globally distributed throughout an 
average lifetime, showing higher values for the beginning and end of life, but without major 
differences between the values. Education costs, however, only exist in the first years of life, 
but represent an important element, as they are large costs and take place at an early stage of 
life, with consequent less impact of the discount factor on the final value. Other elements of 
public expenses – such as costs related to security, sovereignty, defence, etc. – were not directly 
considered. This was so because total costs were considered not to change significantly with 
the existence of one individual – one additional person has a marginal impact and a public good 
with fixed costs will not be sensitive to it. 
Although this study was built on an extensive research, ultimately answering the question 
underlying it, further improvements could be made in subsequent investigations. One would be 
to find more precise and detailed data (e.g. in order to more accurately determine the value for 
initial salary, or to more precisely estimate LTC costs). Furthermore, other variables could be 
considered to enlarge the scope of the investigation. For example, some authors studied the 
difference between the value generated by males versus females – and Molenaar et al (2014) 
inclusively found the NPV of ART-conceived males to be almost three times the value 
generated by females. Other variables to analyse could be the age of the mother (and if it can 
change the NPV in any way), the number of babies born from one single treatment (sharing the 
fixed costs), amongst others. 
Another interesting analysis stemming from this study could be to design strategies to 
enhance the value of ART, after analysing the different scenarios. One strategy could be to 
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optimize the timing and number of cycles per age group, to increase the probability of 
conceiving, while also decreasing the number of multiple pregnancies, which carry more risks. 
Another strategy could be to leverage on the relatively low cost of ART in Portugal to achieve 
a higher return rate. Such an analysis may be important when designing policies for further 
subsidies – and, when doing so, other ethical concerns must be contemplated.  
It is important to consider that ART is expensive for individuals, but affordable from the 
society’s perspective and hence governments may be charged with the responsibility of 
providing it to its citizens. However, ethical concerns remain – does it make sense for ART to 
be a healthcare priority? For one, it does not always exactly correct the problem of infertility – 
it frequently only becomes close to natural reproduction (particularly when it involves gamete 
donation, surrogacy or others, such as for same-sex couples). From a justice and equality 
perspective, does it make sense to finance these procedures, which are not a treatment but rather 
a secondary need, when so many diseases remain untreated? And does it make sense to generate 
life when, simultaneously there were 16.000 abortions in Portugal in 2016 (PorData, 2016)? 
Where can one find and define limits and how do these translate into actual policies? All these 
questions need to be assessed in timely manner, so that ART may be used in a responsible 
manner. Individual and national interests must be aligned when designing policies – never 
forgetting the need to protect minorities, but also remembering to support policies that will be 
sustainable in the long run. 
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Appendix 2 
 
Table 1 – Price references for the currently authorized centres in Portugal 
 
 CGRAB  AVA  MEKA 
 
CEMEARE 
 CETI  
 
Ferticentr
o 
 IVI   GDH (1) 
Código 
(1)
 Preços 
sugeridos 
pela ACSS 
 Média 
Tabela geral de preços
Primeira consulta de fertilidade  €      100.0  €      105.0  €         90.0  €      110.0  €      100.0 57700  €      100.0  €       101.0 
Consulta de ginecologia/ obstetrícia  €      110.0  €      105.0  €         90.0  €       101.7 
Consulta por Skype  €      100.0  €       100.0 
Outras consultas de fertilidade  €      110.0  €         85.0  €      105.0  €       100.0 
Consulta de aconselhamento para doação de gâmetas  €         75.0  €          75.0 
Primeira consulta de psicologia/ psicoterapia  €         65.0  €         95.0  €          80.0 
Segunda consulta de psicologia/ psicoterapia  €         50.0  €          50.0 
Exames de imagem
Ecografia ginecológica (pélvica ou com sonda vaginal)  €         95.0  €      105.0  €       100.0 
Ecografia com sonda vaginal (monitorização de tratamento realizado)  €         75.0  €      105.0  €         60.0  €         65.0  €         80.0  €          77.0 
Ecografia no primeiro trimestre da gravidez (<12 semanas)  €         95.0  €      105.0  €         75.0  €          91.7 
Histeroscopia  €      650.0  €      575.0  €      350.0  €      225.0  €      350.0  €       430.0 
Embrioscopia  €      490.0  €       490.0 
Exame da cavidade do útero (ecografia e contraste)  €      159.0  €       159.0 
Exame da permeabilidade das trompas de Falópio (por ecografia) e Salpingosonografia  €      250.0  €      230.0  €      230.0  €      117.3 57010  €       236.7 
+ anestesia  €      250.0  €      300.0  €      250.0  €       266.7 
Exames de infertilidade masculina e colheita de espermatozóides
Estudo do Esperma (Espermograma)  €         85.0  €         90.0  €      140.0  €         80.0  €         75.0  €         85.0  €         45.8 57200  €          92.5 
Espermocultura  €         30.0  €         30.0  €          30.0 
Biópsia Testicular (para colheita de espermatozóides)  €      850.0  €      700.0  €      840.0  €  1,500.0  €  1,000.0  €      136.9 57220  €       978.0 
Lavagem e preparação de espermatozóides (no caso de parceiro com VIH, VHB, VHC)  €      200.0  €      595.0  €      650.0  €      108.6 57070  €       481.7 
Selecção de espermatozóides por PICSI  €      120.0  €      380.0  €      250.0  €       250.0 
Teste de fragmentação do DNA de espermatozóides  €      150.0  €      150.0  €      145.0  €       148.3 
Teste de migração dos espermatozóides  €         85.0  €          85.0 
Teste de maturidade espérmica (HBA)  €         40.0  €      135.0  €          87.5 
Colheita de ovócitos e outros procedimentos
Punção ovárica c/ colheita de ovócitos p/ Fertilização in vitro (FIV)  €      220.0  €      375.0  €  1,750.0  €      310.0  €  2,500.0  €      180.6 57260  €   1,031.0 
Punção ovárica c/colheita de ovócitos p/Micro-injecção de Gâmetas (ICSI)  €  2,750.0  €   2,750.0 
Scratching do endométrio para auxílio da implantação  €      200.0  €       200.0 
Papanicolau (colheita do esfregaço, envio e citologista)  €         50.0  €          50.0 
Colocação de Dispositivo Intra-Uterino (sem DIU)  €         90.0  €      176.0  €       133.0 
CTG  €         65.0  €         45.0  €          55.0 
Indução da ovulação  €      300.0  €      250.0 57710  €      150.0  €       233.3 
Monitorização da ovulação  €      250.0  €         50.0  €       150.0 
Preparação de ovócitos para microinjecção intracitoplasmática  €      359.1 57100
Biópsia do endométrio com anatomia patológica  €      295.0  €       295.0 
Técnicas de Reprodução Medicamente Assistida
Ciclo sem doação
Inseminação Intrauterina  €      590.0  €      700.0  €      590.0  €      500.0  €      600.0  €      590.0  €      400.0 57720  €      380.0  €       564.3 
Microinjecção Intracitoplasmática  €  4,200.0  €  3,200.0  €  3,400.0  €  3,800.0  €  4,200.0  €      242.1 57120  €  2,613.0  €   3,568.8 
Fertilização In Vitro - Ciclo completo  €  4,200.0  €  3,200.0  €  3,400.0  €  3,800.0  €  4,200.0  €  5,250.0  €  2,500.0 57730  €  2,375.0  €   3,775.0 
            Com embriões criopreservados  €  4,800.0  €   4,800.0 
Injecção intracitoplasmática de espermatozóides recolhidos cirurgicamente (ICSI)  €  2,750.0 57750  €  3,325.0  €   3,325.0 
Ciclo com Doação de Espermatozóides
Inseminação Intrauterina  €      890.0  €      970.0  €      500.0  €      900.0  €  1,040.0  €      900.0  €         38.6  €       866.7 
Fertilização In Vitro/Microinjecção Intracitoplasmática  €  4,500.0  €  4,200.0  €  4,100.0  €  4,650.0  €   4,362.5 
Doação de espermatozóides  €      300.0  €      480.0  €       390.0 
Ciclo com Doação de Ovócitos
Microinjecção Intracitoplasmática  €  6,500.0  €  4,200.0  €  4,200.0  €      242.1 57120  €  2,613.0  €   4,378.3 
Fertilização In Vitro  €  6,500.0  €  4,000.0  €  4,700.0  €  5,500.0  €  7,559.5  €         93.2 57270  €   5,651.9 
           Tratamento com embriões frescos  €  6,300.0  €  5,950.0  €   6,125.0 
           Tratamento com embriões congelados  €  5,300.0  €  7,268.0  €   6,284.0 
Ciclo de Criopreservação de Ovócitos  €  3,100.0  €  2,600.0  €      750.0  €      500.0  €  3,000.0  €         81.9 57300  €   1,990.0 
           Manutenção (por cada período adicional de 5 anos)  €      450.0  €      130.0  €      350.0  €      475.0  €       351.3 
Descongelamento de ovócitos, fertilização e transferência  €  2,200.0  €   2,200.0 
Criopreservação de Espermatozóides  €      500.0  €      335.0  €      350.0  €      350.0  €      250.0  €      450.0  €      217.3 57150  €       372.5 
           De Tecido testicular  €      500.0  €      217.3 57150  €       500.0 
           Manutenção (por cada período adicional de 5 anos)  €      450.0  €      130.0  €      350.0  €      500.0  €      450.0  €       376.0 
Criopreservação de Embriões  €      750.0  €      550.0  €      600.0  €      500.0  €      450.0  €      426.5 57160  €       570.0 
           Manutenção (por período adicional de 3 anos)  €      450.0  €      130.0  €      350.0  €      500.0  €       357.5 
Ciclo de Transferência de Embriões Criopreservados  €      960.0  €  1,100.0  €      900.0  €  1,000.0  €      500.0  €      990.0  €      137.3 57059  €       908.3 
Descongelamento sem transferência  €      385.0  €         80.7 57180  €       385.0 
Assisted hatching  €      210.0  €      300.0  €      290.0  €       266.7 
Identificação e cultura de gâmetas e embriões  €      565.2 57125
Diagnóstico Genético Pré- Implantação
Biópsia Embrionária  €      550.0  €       550.0 
Estudo Genético (génico ou cromossómico)
       FIV + rastreio de aneuploidias  €  5,990.0  €   5,990.0 
Maternidade partilhada (ROPA)  €  4,950.0  €   4,950.0 
Ausência de fecundação  €  2,600.0  €  3,150.0  €  2,000.0  €  2,500.0  €   2,562.5 
Punção sem ovócitos  €  1,995.0  €  1,200.0  €  1,500.0  €  1,990.0  €   1,671.3 
Tratamento freeze all (obtenção, fertilização e transferência posterior)  €  4,600.0  €   4,600.0 
Diagnóstico Genético Pré-Implantação  €      535.4 57005
CGRAB - Centro de Genética da Reprodução Prof. Alberto Barros, AVA - AVA Clinic Centro de Fertilidade de Lisboa, MEKA - Meka Center Clínica da Mulher, CEMEARE - Centro Médico de Assistência à Reprodução, CETI - Centro de Estudo e 
Tratamento da Infertilidade, Ferticentro - Ferticentro Centro de Estudos de Fertilidade, IVI - Clínica IVI Portugal, GDH - Grupos de Diagnóstico Homogéneos, ACSS - Administração Central do Sistema de Saúde, (1) Grupos de Diagnósticos 
Homógeneos, valores de referência para os preços destes procedimentos
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Graph 1 – Total NPV according to the different scenarios 
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Exhibit 1: A broader look into social value of ART 
Besides looking into economic value alone, a broader look was taken at some of the 
involved parties, to better understand how different factors can translate into value change. 
From the infertile couple’s point of view, there are many aspects to consider, such as the already 
mentioned psychological and social costs. It is very important to educate the population for 
adequate fertility care, such as trying to conceive in earlier life stages – infertility should be 
addressed from its very beginning, focusing on prevention, and starting at a community level. 
This is particularly relevant in developing countries, where financial resources are not abundant 
– these are often the same countries where infertility carries the strongest social burden (Cui, 
2010). Developed countries are generally more capable of offering ART services and finding 
ways for couples to access it, but even the most generous policies have limits – from the allowed 
number of cycles, to the timing between procedures. It is interesting to consider the extent to 
which couples are willing to try to have a child, finding solutions such as loans or better 
insurance policies. This willingness to pay together with the different funding alternatives will 
mean that characteristics such as the social status, ethnic background and education of the 
couples undertaking ART will not be as homogeneous as one could initially think (Silvério, 
Feteira, Aldinhas & Fonseca, 2018). Couples that undertake ART procedures are average ones. 
Infertility does indeed have a broad impact on the general society and so does ART. 
Despite the above-mentioned demographic impact, some question whether it should be a health 
priority, especially when budgets are low; furthermore, each country’s social security policies 
carry obligations, with some systems facing insolvency. Many questions arise. How can 
governments consider financing non-existent citizens when so many living ones have specific 
unfulfilled needs? Furthermore, is the desire to have children a fundamental need, and therefore 
a right? Does a country need to guarantee it is fulfilled? These questions were kept in mind 
while developing the model. 
